Stock listing
Aquis:IPHP Innate Pharma SA Share Price
UK listing (Aquis) of Innate Pharma SA · home listing Euronext:IPH
Follow Innate Pharma SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:IPH
€1.26 EUR -0.03 (-2.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:IPH
- Day range
- €1.24 – €1.28 EUROct 30, 2026
- Volume
- 171,440 sharesOct 30, 2026
- Market cap
- €140.3M EURAt the close on Oct 30, 2026 · price × 111.7M shares outstanding
- 52-week range
- €1.03 – €2.33 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- €772,541 EURMedian day 231,304 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:IPH · Home | €1.256 EUR | -0.03 (-2.3%) | 171,440 | €1.274 | €1.28 | €1.244 | €1.286 | Close on Oct 30, 2026 |
| NASDAQ:IPHA | $1.48 USD | -0.02 (-1.3%) | 16,826 | $1.46 | $1.50 | $1.45 | $1.50 | Close on Oct 27, 2026 |
| OTC:IPHYF | $1.509 USD | 0.00 (0.0%) | — | $1.509 | $1.509 | $1.509 | $1.509 | Close on Oct 27, 2026 |
| Frankfurt:IDDA | €1.28 EUR | +0.01 (+0.8%) | — | €1.14 | €1.28 | €1.13 | €1.27 | Close on Oct 30, 2026 |
| Frankfurt:IDD | €1.28 EUR | -0.012 (-0.9%) | — | €1.28 | €1.28 | €1.28 | €1.292 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:IPH · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €1.256 | -0.03 | -2.3% | €1.274 | €1.28 | €1.244 | 171,440 | |
| €1.286 | +0.008 | +0.6% | €1.30 | €1.30 | €1.278 | 83,557 | |
| €1.278 | +0.006 | +0.5% | €1.27 | €1.326 | €1.25 | 130,045 | |
| €1.272 | -0.03 | -2.3% | €1.20 | €1.28 | €1.182 | 495,228 | |
| €1.302 | +0.008 | +0.6% | €1.30 | €1.332 | €1.29 | 187,593 | |
| €1.294 | -0.01 | -0.8% | €1.346 | €1.346 | €1.282 | 64,222 | |
| €1.304 | -0.044 | -3.3% | €1.364 | €1.364 | €1.30 | 75,418 | |
| €1.348 | -0.002 | -0.1% | €1.33 | €1.376 | €1.33 | 214,008 | |
| €1.35 | +0.084 | +6.6% | €1.28 | €1.35 | €1.256 | 200,404 | |
| €1.266 | -0.036 | -2.8% | €1.296 | €1.298 | €1.26 | 169,787 | |
| €1.302 | +0.008 | +0.6% | €1.31 | €1.332 | €1.288 | 168,495 | |
| €1.294 | +0.03 | +2.4% | €1.26 | €1.296 | €1.25 | 145,581 | |
| €1.264 | +0.01 | +0.8% | €1.254 | €1.278 | €1.236 | 137,880 | |
| €1.254 | -0.028 | -2.2% | €1.286 | €1.286 | €1.254 | 68,927 | |
| €1.282 | -0.02 | -1.5% | €1.322 | €1.328 | €1.27 | 218,746 | |
| €1.302 | +0.036 | +2.8% | €1.268 | €1.334 | €1.268 | 200,077 | |
| €1.266 | -0.044 | -3.4% | €1.31 | €1.31 | €1.262 | 276,758 | |
| €1.31 | -0.012 | -0.9% | €1.322 | €1.338 | €1.306 | 295,155 | |
| €1.322 | +0.002 | +0.2% | €1.358 | €1.374 | €1.31 | 281,096 | |
| €1.32 | +0.004 | +0.3% | €1.32 | €1.354 | €1.31 | 191,073 | |
| €1.316 | -0.034 | -2.5% | €1.366 | €1.37 | €1.31 | 237,363 | |
| €1.35 | -0.052 | -3.7% | €1.40 | €1.40 | €1.35 | 204,549 | |
| €1.402 | +0.034 | +2.5% | €1.36 | €1.42 | €1.336 | 261,593 | |
| €1.368 | -0.052 | -3.7% | €1.448 | €1.448 | €1.35 | 243,251 | |
| €1.42 | -0.022 | -1.5% | €1.442 | €1.466 | €1.414 | 521,187 | |
| €1.442 | -0.008 | -0.6% | €1.464 | €1.468 | €1.40 | 357,243 | |
| €1.45 | -0.074 | -4.9% | €1.52 | €1.534 | €1.45 | 332,311 | |
| €1.524 | -0.014 | -0.9% | €1.544 | €1.558 | €1.524 | 154,124 | |
| €1.538 | -0.018 | -1.2% | €1.55 | €1.554 | €1.514 | 230,899 | |
| €1.556 | -0.024 | -1.5% | €1.578 | €1.606 | €1.55 | 176,314 | |
| €1.58 | -0.03 | -1.9% | €1.61 | €1.65 | €1.57 | 280,972 | |
| €1.61 | +0.05 | +3.2% | €1.69 | €1.69 | €1.61 | 994,826 | |
| €1.56 | +0.012 | +0.8% | €1.548 | €1.566 | €1.532 | 317,138 | |
| €1.548 | -0.02 | -1.3% | €1.552 | €1.58 | €1.53 | 230,767 | |
| €1.568 | -0.02 | -1.3% | €1.588 | €1.598 | €1.536 | 231,304 | |
| €1.588 | -0.006 | -0.4% | €1.60 | €1.606 | €1.58 | 177,182 | |
| €1.594 | -0.064 | -3.9% | €1.658 | €1.676 | €1.59 | 265,287 | |
| €1.658 | -0.052 | -3.0% | €1.70 | €1.718 | €1.654 | 204,246 | |
| €1.71 | +0.01 | +0.6% | €1.684 | €1.716 | €1.684 | 154,723 | |
| €1.70 | -0.052 | -3.0% | €1.738 | €1.758 | €1.674 | 429,379 | |
| €1.752 | -0.026 | -1.5% | €1.768 | €1.77 | €1.74 | 245,458 | |
| €1.778 | -0.022 | -1.2% | €1.832 | €1.836 | €1.752 | 229,104 | |
| €1.80 | +0.018 | +1.0% | €1.794 | €1.856 | €1.772 | 278,416 | |
| €1.782 | -0.062 | -3.4% | €1.864 | €1.864 | €1.782 | 431,118 | |
| €1.844 | -0.032 | -1.7% | €1.894 | €1.90 | €1.81 | 325,399 | |
| €1.876 | -0.002 | -0.1% | €1.906 | €1.966 | €1.868 | 385,563 | |
| €1.878 | +0.034 | +1.8% | €1.86 | €1.898 | €1.824 | 194,270 | |
| €1.844 | -0.034 | -1.8% | €1.884 | €1.904 | €1.812 | 359,696 | |
| €1.878 | 0.00 | 0.0% | €1.878 | €1.89 | €1.842 | 245,855 | |
| €1.878 | -0.03 | -1.6% | €1.92 | €1.928 | €1.806 | 595,519 | |
| €1.908 | +0.128 | +7.2% | €1.84 | €1.938 | €1.804 | 992,954 | |
| €1.78 | -0.004 | -0.2% | €1.80 | €1.85 | €1.746 | 471,343 | |
| €1.784 | +0.01 | +0.6% | €1.76 | €1.806 | €1.722 | 560,997 | |
| €1.774 | -0.032 | -1.8% | €1.806 | €1.848 | €1.76 | 760,073 | |
| €1.806 | -0.052 | -2.8% | €1.934 | €1.94 | €1.806 | 1,219,837 | |
| €1.858 | -0.332 | -15.2% | €1.85 | €1.918 | €1.754 | 3,265,569 | |
| €2.19 | +0.02 | +0.9% | €2.23 | €2.33 | €2.17 | 1,602,968 | |
| €2.17 | +0.27 | +14.2% | €1.962 | €2.275 | €1.95 | 2,544,389 | |
| €1.90 | +0.068 | +3.7% | €1.85 | €1.988 | €1.774 | 1,384,177 | |
| €1.832 | +0.324 | +21.5% | €1.798 | €1.95 | €1.71 | 3,127,770 | |
| €1.508 | -0.014 | -0.9% | €1.524 | €1.55 | €1.508 | 144,206 | |
| €1.522 | -0.012 | -0.8% | €1.52 | €1.55 | €1.52 | 44,915 | |
| €1.534 | 0.00 | 0.0% | €1.55 | €1.55 | €1.51 | 63,316 | |
| €1.534 | +0.006 | +0.4% | €1.55 | €1.552 | €1.516 | 98,459 | |
| €1.528 | -0.002 | -0.1% | €1.558 | €1.558 | €1.522 | 84,761 | |
| €1.53 | -0.026 | -1.7% | €1.592 | €1.592 | €1.53 | 76,101 | |
| €1.556 | -0.022 | -1.4% | €1.56 | €1.576 | €1.54 | 77,758 |
- Ticker
- Aquis:IPHP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Aquis
- Currency
- EUR
What changed lately
Latest news release · Oct 27, 2026
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
Latest earnings call · May 13, 2026
Innate Pharma (Euronext:IPH) Q1 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Q2 2026 Earnings Presentation
Earnings · 34 slides
Calls
Replays
Innate Pharma (Euronext:IPH) Q1 2026 Earnings Call
Wed, May 13, 2026 · 7:30 AM ET
Watch TranscriptInnate Pharma (Euronext:IPH) Q4 2025 Earnings Call
Thu, Mar 26, 2026 · 9:00 AM ET
Watch TranscriptInnate Pharma (Euronext:IPH) Q3 2025 Earnings Call
Thu, Nov 13, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
Oct 27, 2026
Closed €1.27 (-2.3%) on Oct 27, 2026
Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
Oct 21, 2026
Closed €1.35 (-0.1%) on Oct 21, 2026
Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update
Oct 20, 2026
Closed €1.35 (+6.6%) on Oct 20, 2026
Innate Pharma Reports First Half 2026 Business Update and Financial Results
Sep 17, 2026
Closed €1.61 (+3.2%) on Sep 17, 2026
Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions
Sep 16, 2026
Closed €1.61 (+3.2%) on Sep 17, 2026
Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update
Sep 10, 2026
Closed €1.59 (-3.9%) on Sep 10, 2026
Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 2, 2026
Closed €1.80 (+1.0%) on Sep 2, 2026
Innate Pharma Announces Pricing of €30 million Offering of Ordinary Shares
Aug 14, 2026
Closed €1.86 (-15.2%) on Aug 14, 2026
Innate Pharma Announces Proposed Offering of Ordinary Shares
Aug 13, 2026
Closed €1.86 (-15.2%) on Aug 14, 2026
Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
Aug 10, 2026
Closed €1.83 (+21.5%) on Aug 10, 2026
Financings
Private placement of new ordinary shares
Aug 14, 2026 · US$34.72M
Update: about €30M · €1.7 a share · Stifel +1
Dealers: Stifel (lead), BTIG (co-lead)
Buyers: Bpifrance Participations S.A. (committed to place a €3 million order in the book)
Use of proceeds: Clinical development of IPH4502, advancing preclinical ADC portfolio candidates, working capital and general corporate purposes
Decks
Q2 2026 Earnings Presentation
Earnings · 34 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 25 slides · May 13, 2026
Investor Presentation (May 2026)
Investor deck · 39 slides · May 2026
Investor Presentation (March 2026)
Investor deck · 40 slides · Mar 26, 2026
Innate Pharma SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 37 in the last 12 months · 57 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 15 calls with a replay · 15 with a transcript · latest May 13, 2026
- Decks
- 76 decks · latest August 2026
Where Innate Pharma SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:IPH · Home listing | Euronext | France | EUR |
| NASDAQ:IPHA | NASDAQ | United States | USD |
| gettex:IDD | gettex | Germany | EUR |
| EUROTLX:4IPH | EUROTLX | Italy | EUR |
| OTC:IPHYF | OTC | United States | USD |
| LSIN:0EVI | LSIN | United Kingdom | EUR |
| LS Exchange:A0LCUJ | LS Exchange | Germany | EUR |
| Aquis:IPHP | Aquis | United Kingdom | EUR |
| Lang & Schwarz:A0LCUJ | Lang & Schwarz | Germany | EUR |
| Aquis:IPHP · This page | Aquis | United Kingdom | EUR |
| Stuttgart:IDD | Stuttgart | Germany | EUR |
| Xetra:IDD | Xetra | Germany | EUR |
| Tradegate:IDD | Tradegate | Germany | EUR |
| Frankfurt:IDDA | Frankfurt | Germany | EUR |
| BOATS:IPHA | BOATS | United States | USD |
| gettex:IDDA | gettex | Germany | EUR |
| Frankfurt:IDD | Frankfurt | Germany | EUR |
| Dusseldorf:IDD | Dusseldorf | Germany | EUR |
| Hamburg:IDD | Hamburg | Germany | EUR |
| Lang & Schwarz:A2PSSH | Lang & Schwarz | Germany | EUR |
| Munich:IDD | Munich | Germany | EUR |
| Munich:IDDA | Munich | Germany | EUR |
| LS Exchange:A2PSSH | LS Exchange | Germany | EUR |
| Stuttgart:IDDA | Stuttgart | Germany | EUR |
| Turquoise:IPHP | Turquoise | United Kingdom | EUR |
| Hanover:IDD | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Innate Pharma SA.